Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ICICI Bank Limited Common Stock (IBN) vs ImmunityBio Inc. Common Stock (IBRX) Price & Performance

ICICI Bank Limited Common StockTrade
ImmunityBio Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

ICICI Bank Limited Common Stock vs ImmunityBio Inc. Common Stock — how do they compare? ICICI Bank Limited Common Stock trades at $28 (market cap $100.09B), while ImmunityBio Inc. Common Stock trades at $9.98 (market cap $10.51B). The key difference: ICICI Bank Limited Common Stock is far larger — about 9.5× ImmunityBio Inc. Common Stock's market cap, and ICICI Bank Limited Common Stock pays a 0.9% dividend while ImmunityBio Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold ICICI Bank Limited Common Stock for 0 Days and ImmunityBio Inc. Common Stock for 0 Days on average.

IBNIBRX
Market Cap
$100.09B$10.51B
Volume
5,088,98310,445,785
Sector
FinancialsHealth
52-Week High
$32.94$11.55
52-Week Low
$25.20$1.98
Typical Hold Time
0 Days0 Days
Enterprise Value
$10.03T$10.97B
Dividend Yield
0.9%—

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

IBN
100% Buy0% Sell
Avg holding period · 0 Days
IBRX
100% Buy0% Sell
Avg holding period · 0 Days

About ICICI Bank Limited Common Stock

ICICI Bank is an Indian financial services company providing banking, lending, cards, insurance, and investment products. It serves retail, business, and corporate customers.

Read more on IBN →

About ImmunityBio Inc. Common Stock

ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.

Read more on IBRX →